patented technology to grow and expand adult Stem Cells
Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

  • Aim to develop and manufacture the best technology graphite in the world
  • Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: here you go..tony ryals, conspiracy theorist and left leaning

Generic_profile
Rank: [?]
Treasurer
Points: [?]
13873
Rating: [?]
Votes: 71 Score: 2.4
  • Currently 2.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

here you go..tony ryals, conspiracy theorist and left leaning

posted on Jul 08, 08 07:04AM

In his column, Mr. Byron made reference to Tony Ryals, who, he wrote, “has been bombarding the S.E.C. and Internet message boards for years with claims that he has uncovered a submerged world of In-Q-Tel-linked fraud stretching for Kuala Lumpur to the Middle East.”

According to Mr. Byron, Mr. Ryals’ complaints earlier this month were picked up by a “left-leaning Web site” that “reported that S.E.C. investigators think the C.I.A.-backed venture fund has been steering money into penny stock ‘pump and dump’ firms in Israel, Dubai and Malaysia.”

The firm’s linkages “are bewildering in their complexity” and “typically impossible to follow,” Mr. Byron wrote, “but conspiracy buffs find them irresistible.” As does, apparently, at least one newspaper columnist.

Mr. Byron’s declaration that In-Q-Tel “continues to funnel agency money into penny stock and micro-cap companies in Wall Street’s murkiest back alleys” is also countered in The Red Herring. “In-Q-Tel does not invest in public companies,” Mr. Tighe said. Further, it has “no involvement in any of those countries mentioned” by Mr. Ryals.

Go to Article from The New York Post »

New Message

Please login to post a reply

AGORACOM Quick Tips

Breaking Small-Cap News Delivered to your Smart Phone! Grab our RSS Feed

President's D.D.

4-17-12, Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial for the treatment of peripheral artery disease (PAD). read more

Stock Quote

Hub Leaders